654083-34-8

Basic information

• Product Name: 1,3-Propanedione, 1-(3,4-dimethoxyphenyl)-3-(2-hydroxy-3,4,5,6-tetramethoxyphenyl)-
• CAS NO: 654083-34-8
• Molecular Formula: C21H24O9
• Molecular Weight: 420.416
• Mol File: 654083-34-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1,3-Propanedione, 1-(3,4-dimethoxyphenyl)-3-(2-hydroxy-3,4,5,6-tetramethoxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-Propanedione, 1-(3,4-dimethoxyphenyl)-3-(2-hydroxy-3,4,5,6-tetramethoxyphenyl)-(654083-34-8)
• EPA Substance Registry System: 1,3-Propanedione, 1-(3,4-dimethoxyphenyl)-3-(2-hydroxy-3,4,5,6-tetramethoxyphenyl)-(654083-34-8)

Safety Data

• Hazardous Substances Data: 654083-34-8(Hazardous Substances Data)

Upstream product

• 14786-40-4 1-(2,3,4,5,6-pentamethoxyphenyl)ethan-1-one 
• 91556-09-1 2,3,4,5,6-pentamethoxybenzoic acid 
• 92157-76-1 methyl 2,3,4,5,6-pentamethoxybenzoate 
• 2103-57-3 2,3,4-trimethoxybenzaldehyde 
• 93-07-2 Veratric acid 
• 56002-80-3 2-acetoxy-1,3,4,5-tetramethoxybenzene 
• 53887-77-7 2-hydroxy-3,4,5,6-tetramethoxybenzene 
• 86475-21-0 2,3,4,5-tetramethoxyphenylformate 
• 19676-64-3 2,3,4-trimethoxyphenol 
• 65884-12-0 2,3,4,5-tetramethoxybenzaldehyde 
• 7508-05-6 1-(2,3,4,6-tetramethoxyphenyl)ethanone 
• 7507-98-4 1-(2-hydroxy-3,4,6-trimethoxyphenyl)ethanone 
• 5333-45-9 1,2,3,5-tetramethoxybenzene 
• 21450-56-6 1,2,3,4-tetramethoxybenzene 

Downstream Products

• 2174-59-6 5-hydroxy-6,7,8,3',4'-pentamethoxyflavone 
• 478-01-3 nobiletin 

Relevant articles and documents

preparing methods of nobiletin

The present invention provides a process for preparing nobiletin. The present invention relates to a method for preparing nobiletin by using a specific reagent.

PET imaging of nobiletin based on a practical total synthesis

A practical synthesis of nobiletin, a polymethoxylated citrus flavone, was accomplished by utilizing our novel flavone synthesis. Synthetic nobiletin was labelled by selective demethylation and rapid incorporation of 11C atom. Positron emission tomography images successfully visualized the brain distribution, which may provide therapeutic benefits in the treatment of Alzheimer's disease. The Royal Society of Chemistry.